Article Correctness Is Author's Responsibility: A sleeping pill that doesn’t make you sway: a new targeted insomnia treatment

(University of Tsukuba) University of Tsukuba researchers compared the physical and cognitive side effects of two sleep agents that affect two different kinds of brain receptor. Brotizolam, commonly prescribed for insomnia in Japan, affects GABA receptors, which are present throughout the brain. A newer agent, suvorexant, affects receptors that are specifically involved in wakefulness. Suvorexant was just as effective as brotizolam in terms of sleep duration and efficiency, and had fewer body balance side effects. Future large-scale trials are warranted.